Wall Street Pummels HTA After Recent Earnings Report

Healthcare Trust of America, Inc. (NYSE:HTA) went down by -0.37% from its latest closing price compared to the recent 1-year high of $34.22. The company’s stock price has collected 2.05% of gains in the last five trading sessions. Press Release reported 22 hours ago that Healthcare Trust of America Announces Pricing of $800 million of 2.000% Senior Unsecured Notes Due 2031

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is It Worth Investing in Healthcare Trust of America, Inc. (NYSE :HTA) Right Now?

Healthcare Trust of America, Inc. (NYSE:HTA) scored a price-to-earnings ratio above its average ratio, recording 187.90 x from its present earnings ratio. Plus, the 36-month beta value for HTA is at 0.53. Opinions of the stock are interesting as 9 analysts out of 14 who provided ratings for Healthcare Trust of America, Inc. declared the stock was a “buy,” while 2 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

The average price from analysts is $29.69, which is $2.8 above the current price. HTA currently public float of 217.54M and currently shorts hold a 5.20% ratio of that float. Today, the average trading volume of HTA was 1.76M shares.

HTA’s Market Performance

HTA stocks went up by 2.05% for the week, with a monthly jump of 4.55% and a quarterly performance of -6.93%, while its annual performance rate touched -4.58%. The volatility ratio for the week stands at 2.79% while the volatility levels for the past 30 days are set at 2.58% for Healthcare Trust of America, Inc.. The simple moving average for the period of the last 20 days is 3.17% for HTA stocks with a simple moving average of -3.16% for the last 200 days.

Analysts’ Opinion of HTA

Many brokerage firms have already submitted their reports for HTA stocks, with Stifel repeating the rating for HTA by listing it as a “Buy.” The predicted price for HTA in the upcoming period, according to Stifel is $32 based on the research report published on September 2nd of the current year 2020.

Raymond James, on the other hand, stated in their research note that they expect to see HTA reach a price target of $29. The rating they have provided for HTA stocks is “Outperform” according to the report published on August 31st, 2020.

BTIG Research gave a rating of “ Neutral” to HTA, setting the target price at $29 in the report published on March 16th of the current year.

HTA Trading at 1.98% from the 50-Day Moving Average

After a stumble in the market that brought HTA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.48% of loss for the given period.

Volatility was left at 2.58%, however, over the last 30 days, the volatility rate increased by 2.79%, as shares surge +4.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.41% upper at present.

During the last 5 trading sessions, HTA rose by +2.05%, which changed the moving average for the period of 200-days by -12.28% in comparison to the 20-day moving average, which settled at $26.11. In addition, Healthcare Trust of America, Inc. saw -11.26% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HTA starting from Milligan Robert A, who bought 2,000 shares at the price of $23.75 back on May 15. After this action, Milligan Robert A now owns 170,212 shares of Healthcare Trust of America, Inc., valued at $47,500 using the latest closing price.

FIX WARREN D, the Director of Healthcare Trust of America, Inc., bought 1,000 shares at $24.99 during a trade that took place back on May 12, which means that FIX WARREN D is holding 69,052 shares at $24,990 based on the most recent closing price.

Stock Fundamentals for HTA

Current profitability levels for the company are sitting at:

  • +7.46 for the present operating margin
  • +27.82 for the gross margin

The net margin for Healthcare Trust of America, Inc. stands at +4.38. The total capital return value is set at 0.84, while invested capital returns managed to touch 0.51. Equity return is now at value 1.00, with 0.50 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Based on Healthcare Trust of America, Inc. (HTA), the company’s capital structure generated 87.80 points at debt to equity in total, while total debt to capital is 46.75. Total debt to assets is 44.41, with long-term debt to equity ratio resting at 1.53. Finally, the long-term debt to capital ratio is 84.59.

When we switch over and look at the enterprise to sales, we see a ratio of 13.54, with the company’s debt to enterprise value settled at 0.32. The receivables turnover for the company is 5.28 and the total asset turnover is 0.11.

Related Articles

Syneos Health Inc. (SYNH) and the Battle of Fundamentals vs. Technicals

Syneos Health Inc. (NASDAQ:SYNH) went up by 0.57% from its latest closing price compared to the recent 1-year high of $74.25. The company’s stock...

The Chart for Invitae Corporation (NVTA) Is Flashing Mixed Signals

Invitae Corporation (NYSE:NVTA) went up by 4.59% from its latest closing price compared to the recent 1-year high of $44.03. The company’s stock price...

Here’s Our Rant About Xeris Pharmaceuticals Inc. (XERS)

Xeris Pharmaceuticals Inc. (NASDAQ:XERS) went up by 2.86% from its latest closing price compared to the recent 1-year high of $10.13. The company’s stock...

Latest Posts

Syneos Health Inc. (SYNH) and the Battle of Fundamentals vs. Technicals

Syneos Health Inc. (NASDAQ:SYNH) went up by 0.57% from its latest closing price compared to the recent 1-year high of $74.25. The company’s stock...

The Chart for Invitae Corporation (NVTA) Is Flashing Mixed Signals

Invitae Corporation (NYSE:NVTA) went up by 4.59% from its latest closing price compared to the recent 1-year high of $44.03. The company’s stock price...

Here’s Our Rant About Xeris Pharmaceuticals Inc. (XERS)

Xeris Pharmaceuticals Inc. (NASDAQ:XERS) went up by 2.86% from its latest closing price compared to the recent 1-year high of $10.13. The company’s stock...

Here is How Warren Buffer Would Trade Beyond Meat Inc. (BYND)

Beyond Meat Inc. (NASDAQ:BYND) went up by 4.81% from its latest closing price compared to the recent 1-year high of $167.16. The company’s stock...

Here’s How Your Trade COMM Aggressively Right Now

CommScope Holding Company Inc. (NASDAQ:COMM) went up by 0.71% from its latest closing price compared to the recent 1-year high of $15.79. The company’s...